Telitromicine. A new therapeutic option from macrolides to ketolides.

Telitromicine. A new therapeutic option from macrolides to ketolides.

-<br />

Saved in:

Bibliographic Details
Main Authors:	Pedro Miguel Milián Vázquez., Maira Quirós Enríquez., Arlette Linares Borges.
Format:	Article
Language:	Spanish
Published:	Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2004-08-01
Series:	Medisur
Online Access:	http://medisur.sld.cu/index.php/medisur/article/view/61
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The usage of sustained-action theophyline in the intercrisis treatment of bronchial asthma.
by: Yaquelín Martínez Chavez., et al.
Published: (2004-04-01)

Evaluation of the pharmacological treatment of arterial hypertension associated to heart failure in Camarones town.
by: Pedro Miguel Milián Vázquez., et al.
Published: (2006-12-01)

In Vitro Activity of New Macrolides against Respiratory Pathogens
by: Michel G Bergeron
Published: (1993-01-01)

Future Uses of Newer Macrolides
by: John Segreti
Published: (1993-01-01)

Oxazolidinones as an Alternative in the Treatment of Multiresistant Staphylococcus Aureus
by: Maira Quiros Enríquez, et al.
Published: (2013-04-01)

Macrolides in Chronic Inflammatory Skin Disorders
by: Abdullateef A. Alzolibani, et al.
Published: (2012-01-01)

Drug Utilization Studies as Content of the Professional Development of Physicians
by: Yacelis Dahilet Cisneros Nápoles, et al.
Published: (2014-04-01)

Automedicación en trabajadores de la Facultad de Ciencias Médicas de Cienfuegos
by: Maira Quiros Enríquez, et al.
Published: (2012-12-01)

Therapeutic Options for the Management of the Cardiorenal Syndrome
by: Katerina Koniari, et al.
Published: (2011-01-01)

Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro
by: Ken-Ichi Kanai, et al.
Published: (2004-01-01)

Phenotypic Resistance of (MRSA) Clinical Isolates to Some Macrolide Antibiotic Groups
by: Ali Yaseen, et al.
Published: (2023-12-01)

New Spectrophotometric and Conductometric Methods for Macrolide Antibiotics Determination in Pure and Pharmaceutical Dosage Forms Using Rose Bengal
by: Rania A. Sayed, et al.
Published: (2013-01-01)

Therapeutic Options for Patients Bleeding with Peptic Ulcers
by: ABR Thomson
Published: (1994-01-01)

Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
by: Toshikazu Shimane, et al.
Published: (2001-01-01)

Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice
by: Hajime Terao, et al.
Published: (2003-01-01)

Simultaneous determination of macrolides in water samples by solid-phase extraction and capillary electrophoresis
by: Pavlović Dragana Mutavdžić, et al.
Published: (2023-12-01)

Updates on the development of vaccines and therapeutic options against rabies
by: Roshan Arjun Ananda, et al.
Published: (2020-08-01)

Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications
by: Gabriele Togliatto, et al.
Published: (2015-01-01)

New Methods with Capped Options for Pricing American Options
by: Dongya Deng, et al.
Published: (2014-01-01)

Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes
by: Wendy I Sligl, et al.
Published: (2013-01-01)

Penicillin Susceptibility and Macrolide-Lincosamide-Streptogramin B Resistance in Group B Streptococcus Isolates from a Canadian Hospital
by: Kevin Sherman, et al.
Published: (2012-01-01)

Editorial: Understanding obesity to determine the best therapeutic option: from lifestyle interventions to therapies
by: Evelyn Frias-Toral, et al.
Published: (2025-02-01)

Professional Development Program Aimed at Physicians to Develop Drug Utilization Studies
by: Yacelis Dahilet Cisneros Nápoles, et al.
Published: (2014-04-01)

Suppressive Activity of a Macrolide Antibiotic, Roxithromycin, on Pro-Inflammatory Cytokine Production in Vitro and in Vivo
by: H. Suzaki, et al.
Published: (1999-01-01)

Ivermectin as a promising therapeutic option for onchocerciasis‐associated epilepsy
by: Mohammad Amin Manavi, et al.
Published: (2025-02-01)

Monkeypox: Origin, Transmission, Clinical Manifestations, Prevention, and Therapeutic Options
by: Sajal Kumar Halder, et al.
Published: (2025-01-01)

Application of dexlansoprazole to broaden therapeutic options for gastroesophageal reflux disease
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

MENINGIOMAS IN DOGS: EPIDEMIOLOGY, ADVANCEMENTS IN DIAGNOSTIC IMAGING AND THERAPEUTIC OPTIONS
by: Sorin Marian Mârza, et al.
Published: (2025-01-01)

Current Strategies for Cancer Management: an Analysis of Therapeutic and Prevention Options
by: Carlos David Castañeda Guillot, et al.
Published: (2024-10-01)

Non-Drug and Non-Invasive Therapeutic Options in Alzheimer’s Disease
by: Alina Simona Șovrea, et al.
Published: (2025-01-01)

Combined therapeutic option for NDM-producing Serratia Marcescens – an in vitro study from clinical samples
by: Balbina Chilombo Albano, et al.
Published: (2025-01-01)

Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
by: Carmen Rodriguez-Cerdeira, et al.
Published: (2012-01-01)

Are atypical antipsychotic medications better than the conventional ones?
by: Pedro Miguel Milián Vázquez., et al.
Published: (2005-04-01)

Current and future therapeutic options for chronic hepatitis D virus infection
by: Mariantonietta Pisaturo, et al.
Published: (2025-02-01)

Factors influencing bone loss in anorexia nervosa: assessment and therapeutic options
by: Isabelle Legroux, et al.
Published: (2019-11-01)

Lactic Acid Regulation: A Potential Therapeutic Option in Rheumatoid Arthritis
by: Qianlei Wang, et al.
Published: (2022-01-01)

Endoscopic submucosal dissection for proximal colonic lesions: An effective therapeutic option
by: Ludovico Alfarone, et al.
Published: (2025-01-01)

MOLAR INCISOR HYPOMINERALIZATION (MIH) – THERAPEUTIC OPTIONS FOR THE FIRST PERMANENT MOLARS
by: Olimpia Bunta, et al.
Published: (2024-12-01)

Blocking Type I Interferon Production: A New Therapeutic Option to Reduce the HIV-1-Induced Immune Activation
by: Moritz Ries, et al.
Published: (2012-01-01)

Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
by: Rosalba Parenti, et al.
Published: (2014-01-01)